BioSpace News Archive

Leading telehealth enabled habit change platform is a CDC fully accredited alternate diabetes prevention program

NantKwest, Inc., a clinical-stage, natural killer cell-based therapeutics company, announced the pricing of an underwritten public offering of an aggregate of 7,410,000 shares of its common stock.

Complementary expertise provides a single vendor solution to streamline data workflows from ‘instrument to insight’, boosting research efficiency

Leading Singapore Distributor EO Medical Accelerates Alliance with Los Angeles-Based UV-C Disinfecting Robot Manufacturer to Help Prevent the Spread of COVID-19

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, announced that the first COVID-19 patient has been dosed in a Phase 2 study of TD-0903.

Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that a new study published in Future Medicine demonstrates the ability of myPath® Melanoma to accurately classify skin lesions ruled indeterminate by standard pathological review.

Company expands program to award 25 grants totaling $125,000 to fund nonprofit, community-based organizations supporting individuals with sickle cell disease and beta-thalassemia

BSM Partners, the leading pet care research and consulting firm, calls on their peers in the veterinary, veterinary cardiology, animal nutrition, and related fields to undertake studies that produce appropriately controlled, original research to determine the relationship between canine diets and dilated cardiomyopathy.

Multi-center trial to evaluate the safety and efficacy of pelareorep-anti-PD-1 combination therapy in triple-negative breast cancer, an indication of continued unmet medical need

At the American Association for Cancer Research 2020 Virtual Annual Meeting II, AnchorDx presented a poster unveiling a new generation of ctDNA methylation detection technology, named Aurora, for multi-cancer screening, titled Toward the Development of a $100 Screening Test for Six Major Cancer Types.